Simplex Trading’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.53M | Buy |
+7,753
| New | +$1.49M | ﹤0.01% | 2068 |
|
|
2025
Q4 | – | Sell |
-29,742
| Closed | -$5.22M | – | 8534 |
|
|
2025
Q3 | $4.56M | Sell |
29,742
-20,905
| -41% | -$3.16M | ﹤0.01% | 1547 |
|
|
2025
Q2 | $7.08M | Buy |
+50,647
| New | +$7.1M | ﹤0.01% | 1103 |
|
|
2025
Q1 | – | Sell |
-2,754
| Closed | -$398K | – | 8506 |
|
|
2024
Q4 | $360K | Sell |
2,754
-12,892
| -82% | -$1.8M | ﹤0.01% | 3872 |
|
|
2024
Q3 | $2.44M | Buy |
+15,646
| New | +$2.53M | ﹤0.01% | 2108 |
|
|
2024
Q2 | – | Sell |
-58,402
| Closed | -$8.79M | – | 8760 |
|
|
2024
Q1 | $7.91M | Buy |
+58,402
| New | +$7.73M | ﹤0.01% | 1275 |
|
|
2023
Q3 | – | Sell |
-16,654
| Closed | -$2.27M | – | 8647 |
|
|
2023
Q2 | $2.38M | Buy |
+16,654
| New | +$2.45M | ﹤0.01% | 1831 |
|
|
2023
Q1 | – | Sell |
-27,340
| Closed | -$3.68M | – | 8993 |
|
|
2022
Q4 | $3.71M | Buy |
+27,340
| New | +$3.43M | ﹤0.01% | 1417 |
|
|
2022
Q1 | – | Sell |
-115,598
| Closed | -$13.9M | – | 10360 |
|
|
2021
Q4 | $13.5M | Buy |
+115,598
| New | +$13.6M | 0.01% | 660 |
|
|
2021
Q2 | – | Sell |
-25,732
| Closed | -$2.82M | – | 10013 |
|
|
2021
Q1 | $0 | Sell |
25,732
-85,035
| -77% | -$8.55M | ﹤0.01% | 8774 |
|
|
2020
Q4 | $11.1M | Buy |
110,767
+68,455
| +162% | +$7.25M | 0.01% | 541 |
|
|
2020
Q3 | $4.64M | Buy |
42,312
+11,928
| +39% | +$1.33M | 0.01% | 918 |
|
|
2020
Q2 | $3.21M | Buy |
30,384
+27,589
| +987% | +$2.85M | 0.01% | 1144 |
|
|
2020
Q1 | $249K | Sell |
2,795
-3,077
| -52% | -$290K | ﹤0.01% | 3336 |
|
|
2019
Q4 | $585K | Sell |
5,872
-2,421
| -29% | -$228K | ﹤0.01% | 2590 |
|
|
2019
Q3 | $739K | Buy |
8,293
+3,764
| +83% | +$326K | ﹤0.01% | 2241 |
|
|
2019
Q2 | $373K | Buy |
+4,529
| New | +$355K | ﹤0.01% | 2865 |
|
|
2019
Q1 | – | Sell |
-8,118
| Closed | -$640K | – | 7115 |
|
|
2018
Q4 | $616K | Sell |
8,118
-3,203
| -28% | -$250K | ﹤0.01% | 2038 |
|
|
2018
Q3 | $895K | Buy |
11,321
+4,388
| +63% | +$332K | ﹤0.01% | 2009 |
|
|
2018
Q2 | $486K | Sell |
6,933
-34,199
| -83% | -$2.46M | ﹤0.01% | 2487 |
|
|
2018
Q1 | $2.88M | Buy |
+41,132
| New | +$2.85M | 0.13% | 137 |
|
|
2017
Q3 | – | Sell |
-85,041
| Closed | -$5.37M | – | 5871 |
|
|
2017
Q2 | $5.8M | Buy |
85,041
+64,356
| +311% | +$4.2M | 0.25% | 61 |
|
|
2017
Q1 | $1.29M | Sell |
20,685
-12,076
| -37% | -$703K | 0.06% | 306 |
|
|
2016
Q4 | $1.79M | Sell |
32,761
-35,852
| -52% | -$2.04M | 0.11% | 159 |
|
|
2016
Q3 | $4.51M | Buy |
68,613
+48,544
| +242% | +$3.17M | 0.31% | 50 |
|
|
2016
Q2 | $1.21M | Buy |
20,069
+13,545
| +208% | +$787K | 0.08% | 226 |
|
|
2016
Q1 | $367K | Buy |
+6,524
| New | +$392K | 0.03% | 571 |
|
|
2015
Q3 | – | Sell |
-4,164
| Closed | -$274K | – | 5481 |
|
|
2015
Q2 | $265K | Buy |
+4,164
| New | +$285K | 0.02% | 657 |
|
|
2015
Q1 | – | Sell |
-7,871
| Closed | -$547K | – | 4937 |
|
|
2014
Q4 | $554K | Buy |
+7,871
| New | +$564K | 0.07% | 249 |
|
Other funds holding AZN
IA
VCM
VAM
Simplex Trading's AZN Position: Q1 2026 in Review
Simplex Trading opened a new position in AstraZeneca (AZN) in Q1 2026: 7,753 shares worth $1.53M. The stake represents ﹤0.01% of the portfolio and ranks #2068 among its holdings. This is a return to the name: Simplex Trading previously reported a position in AZN as recently as Q3 2025.
Simplex Trading first reported a position in AZN in Q4 2014 and has held it in 29 quarters since. The position peaked at $13.5M in Q4 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Simplex Trading held 7,753 shares of AstraZeneca worth $1.53M as of Q1 2026.
- AstraZeneca was a new Simplex Trading position in Q1 2026.
- AstraZeneca made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2068 holding.
- Simplex Trading first reported a position in AstraZeneca in Q4 2014 and has held it in 29 quarters since.
- Simplex Trading's AstraZeneca position peaked at $13.5M in Q4 2021.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.